Portfolio company
Cellular Origins
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops an automated robotic platform for cell therapy developers to manufacture and scale autologous and allogeneic therapies.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Ori Biotech
This company develops automated manufacturing platforms for cell and gene therapy developers to scale production of advanced medicines.
Cellino
The company develops an autonomous biomanufacturing platform to produce personalised stem cell therapies for patients with chronic degenerative diseases.
Cellares
This company provides automated manufacturing platforms and services for cell therapy development to biopharmaceutical organisations and academic research centres.
Transforming cells into cures
This company develops a cellular engineering platform to design and optimize cell therapies for biopharmaceutical developers and research institutions.
Cellino Bio
This company develops an autonomous biomanufacturing platform that uses artificial intelligence and lasers to produce personalised cell therapies for patients with degenerative diseases.
Scinus Group
This company develops automated, closed bioreactor systems for large-scale cell expansion, serving the cell therapy and regenerative medicine industries.
iOrganBio
This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.
Limula
Limula develops an automated platform for manufacturing cell and gene therapies to assist therapy developers, hospitals and clinical centres with decentralized production.
